Similar to ASXL1, an inactivating EZH2 mutation has been reported in poor-prognosis leukemia37, whereas a gain-of-function mutation of EZH2 at Tyr641 in lymphoma is distinct from an ASXL1 loss-of-function mutation. The gene discussed is EZH2; the disease is lymphoma.